Sep 21, 2026 09:00AM
Sep 21, 2026 09:00AM
Aug 17, 2026 07:00AM
Jul 30, 2026 04:01PM
Jul 30, 2026 04:01PM
Jun 11, 2026 08:03AM
Jun 11, 2026 08:00AM InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
Jun 8, 2026 08:02AM
Jun 8, 2026 08:00AM
May 4, 2026 04:05PM
May 1, 2026 04:05PM
May 1, 2026 04:05PM
May 1, 2026 04:05PM
Mar 18, 2026 07:00AM InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
Jan 12, 2026 09:00AM
Sep 17, 2025 08:00AM
Sep 17, 2025 08:00AM
Aug 21, 2025 07:00AM
Aug 21, 2025 07:00AM
Aug 5, 2025 08:00AM
Jul 31, 2025 08:32AM InspireMD raises $58 million through equity placement and warrant exercise
Jul 31, 2025 08:30AM
Jul 9, 2025 07:01AM
Jul 9, 2025 07:00AM
Jun 24, 2025 04:06PM
Jun 24, 2025 04:05PM
Jun 13, 2025 09:00AM
Jun 13, 2025 09:00AM InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
May 12, 2025 08:00AM
May 9, 2025 07:00AM
Mar 12, 2025 07:00AM
Feb 13, 2025 07:00AM
Dec 12, 2024 07:00AM
Dec 12, 2024 07:00AM
Dec 9, 2024 07:00AM InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)
Nov 12, 2024 07:00AM
Oct 15, 2024 07:00AM
Oct 7, 2024 07:04AM
Oct 7, 2024 07:00AM
Sep 17, 2024 07:17AM
Sep 16, 2024 07:07AM
Sep 16, 2024 07:00AM InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System
Aug 6, 2024 08:09AM
Aug 5, 2024 07:00AM
Jul 1, 2024 07:00AM
May 28, 2024 08:53AM
May 14, 2024 07:00AM
Jan 31, 2024 07:01AM
Jan 31, 2024 07:00AM InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework
Dec 20, 2023 07:00AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All